Literature DB >> 14647529

Pharmacology of acamprosate: an overview.

Teodoro Zornoza1, María J Cano, Ana Polache, Luis Granero.   

Abstract

In the last years important advances have been made in the development of drugs for the treatment of alcohol addiction. Acamprosate (calcium bis-acetylhomotaurine) is one of the better established drugs in this field on the European market. This review focuses first on the pharmacokinetics of acamprosate. The published data and the recent advances in our knowledge on the mechanisms involved in the intestinal absorption and elimination of this drug are summarized. The importance of pharmacokinetics for the proper clinical use of acamprosate is highlighted. The anti-relapse as well as the well-known effects of acamprosate on ethanol intake are discussed. The recent experiments in animal models of conditioned withdrawal are reviewed. These experiments, explored for the first time the anticraving effect of the drug. Finally, the proposed hypotheses on the neuropharmacological mechanism of action of acamprosate are discussed. The discussion deals with the relative importance of various hypotheses as well as with the recent experiments that support them. It is pointed out that further research is necessary in order to clearly understand the mode of action of acamprosate as well as the neurobiological mechanisms involved in alcohol dependence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14647529      PMCID: PMC6741676          DOI: 10.1111/j.1527-3458.2003.tb00260.x

Source DB:  PubMed          Journal:  CNS Drug Rev        ISSN: 1080-563X


  9 in total

Review 1.  The development of acamprosate as a treatment against alcohol relapse.

Authors:  Peter R Kufahl; Lucas R Watterson; M Foster Olive
Journal:  Expert Opin Drug Discov       Date:  2014-09-26       Impact factor: 6.098

2.  Circadian and acamprosate modulation of elevated ethanol drinking in mPer2 clock gene mutant mice.

Authors:  Allison J Brager; Rebecca A Prosser; J David Glass
Journal:  Chronobiol Int       Date:  2011-10       Impact factor: 2.877

Review 3.  Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.

Authors:  Lesley J Scott; David P Figgitt; Susan J Keam; John Waugh
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Calcium chloride mimics the effects of acamprosate on cognitive deficits in chronic alcohol-exposed mice.

Authors:  Grishma Pradhan; Patrick R Melugin; Fei Wu; Hannah M Fang; Rachel Weber; Sven Kroener
Journal:  Psychopharmacology (Berl)       Date:  2018-04-20       Impact factor: 4.530

5.  Acamprosate-responsive brain sites for suppression of ethanol intake and preference.

Authors:  Allison Brager; Rebecca A Prosser; J David Glass
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-22       Impact factor: 3.619

Review 6.  What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials.

Authors:  David J Heal; Jane Gosden
Journal:  Int J Obes (Lond)       Date:  2022-01-07       Impact factor: 5.551

7.  The Role of Glial Cells in Drug Abuse.

Authors:  Jose Javier Miguel-Hidalgo
Journal:  Curr Drug Abuse Rev       Date:  2009

8.  Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence.

Authors:  David Romeo-Guitart; Joaquim Forés; Mireia Herrando-Grabulosa; Raquel Valls; Tatiana Leiva-Rodríguez; Elena Galea; Francisco González-Pérez; Xavier Navarro; Valerie Petegnief; Assumpció Bosch; Mireia Coma; José Manuel Mas; Caty Casas
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

Review 9.  Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.

Authors:  David J Heal; Sharon L Smith
Journal:  J Psychopharmacol       Date:  2021-07-28       Impact factor: 4.562

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.